A Study of the Relative Bioavailability of ASC18 Tablets vs Reference Tablets in Healthy Volunteers

NCT04358523 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: ASC18
DRUG: ravidasvir and sofosbuvir
DRUG: ASC18

Sponsor

Ascletis Pharmaceuticals Co., Ltd.